Evidence map›Paper›PMID 36559259›Full record

ArticlePharmaceutics2022

Development and Evaluation of Ethosomes Loaded with

Kampanart Huanbutta, Napapat Rattanachitthawat, Kunlathida Luangpraditkun, Pornsak Sriamornsak, Vivek Puri, Inderbir Singh, Tanikan Sangnim

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Bridging bioactive metabolites ofFrontiers in pharmacology · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kampanart HuanbuttaSchool of Pharmacy, Eastern Asia University, Thanyaburi 12110, Thailand.ORCID 0000-0001-8188-153X
Napapat RattanachitthawatFaculty of Pharmaceutical Sciences, Burapha University, Chonburi 20131, Thailand.
Kunlathida LuangpraditkunFaculty of Pharmaceutical Sciences, Burapha University, Chonburi 20131, Thailand.
Pornsak SriamornsakDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.ORCID 0000-0002-5525-1494
Vivek PuriSchool of Pharmacy, Chitkara University, Baddi 174103, India.ORCID 0000-0002-4497-9412
Inderbir SinghChitkara College of Pharmacy, Chitkara University, Rajpura 140401, India.ORCID 0000-0002-1860-4246
Tanikan SangnimFaculty of Pharmaceutical Sciences, Burapha University, Chonburi 20131, Thailand.ORCID 0000-0002-9332-384X

Funding

Faculty of Pharmaceutical Sciences, Burapha University Rx2/2564
6 · The paper itself

Abstract

Skin fungal infection is still a serious public health problem due to the high number of cases. Even though medicines are available for this disease, drug resistance among patients has increased. Moreover, access to medicine is restricted in some areas. One of the therapeutic options is herbal medicine. This study aims to develop an ethosome formulation loaded with

Indexed as

antifungalethosomefungal infectionskin permeationZingiber zerumbet Linn

Identifiers

PMID36559259
PMCPMC9781750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.